- ER-alpha 36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas
[作者:Lee, LMJ; Cao, J; Deng, H; Chen, P; Gatalica, Z; Wang, ZY,期刊:Anticancer Research, 页码:479-483 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The status of estrogen receptor-alpha (ER-a) expression is one of the most important diagnostic and prognostic factors of breast cancer. ER-alpha is a 66-kDa, ligand-induced transcription factor, characterist...
- Photodynamic therapy of Barrett's esophagus: Ablation of Barrett's mucosa and reduction in p53 protein expression after treatment
[作者:Panjehpour, M; Coppola, D; Overholt, BF; Vo-Dinh, T; Overholt, S,期刊:Anticancer Research, 页码:485-489 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The effectiveness of photodynamic therapy (PDT) for ablation of high grade dysplasia (HGD) in Barrett's esophagus (BE) is typically reported histologically. Following successful PDT, Barrett's mucosa is repla...
- Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer
[作者:Lumachi, F; Ermani, M; Marino, F; Di Cristofaro, L; Tombolan, V; Brunello, A; Roma, A; Basso, U,期刊:Anticancer Research, 页码:491-493 , 文章类型: Article,,卷期:2008年28-1B]
- Background: Breast cancer (BC) is the most common cancer in women, and the hormone receptor status is one of the most important prognostic factors in patients with BC. The aim of this study was to establish whether a rel...
- Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: A Multicenter phase II study of the Hellenic Oncology Research Group (HORG)
[作者:Kalykaki, A; Papakotoulas, P; Tsousis, S; Boukovinas, I; Kalbakis, K; Vamvakas, L; Kotsakis, A; Vardakis, N; Papadopoulou, P; Georgoulias, V; Mavroudis, D,期刊:Anticancer Research, 页码:495-500 , 文章类型: Article,,卷期:2008年28-1B]
- The aim of this study was to evaluate the safety and activity of a gemcitabine-oxaliplatin combination (GEMOX) regimen in pretreated patients with advanced ovarian cancer. Twenty-seven platinum-refractory/resistant and 1...
- Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma
[作者:Malusecka, E; Krzyzowska-Gruca, S; Gawrychowski, J; Fiszer-Kierzkowska, A; Kolosza, Z; Krawczyk, Z,期刊:Anticancer Research, 页码:501-506 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The expression pattern of stress (heat shock) proteins (HSPs) in cancer cells is frequently different from that observed in normal cells; most often some stress-inducible HSPs are constitutively and highly ex...
- Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer
[作者:Tiseo, M; Ardizzoni, A; Cafferata, MA; Loprevite, M; Chiaramondia, M; Filiberti, R; Marroni, P; Gross, F; Paganuzzi, M,期刊:Anticancer Research, 页码:507-513 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The Predictive and prognostic role of neuron-specific enolase (NSE) in non-small cell lung cancer (NSCLC) is still under debate. Patients and Methods: To study these aspects, serum NSE was prospectively measu...
- Inguinal sentinel lymph node dissection vs. complete inguinal lymph node dissection in patients with vulvar cancer
[作者:Hefler, LA; Grimm, C; Six, L; Seebacher, V; Polterauer, S; Joura, E; Tempfer, C; Sliutz, G; Reinthaller, A,期刊:Anticancer Research, 页码:515-517 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The aim of this retrospective study was to ascertain the postoperative morbidity in patients with vulvar cancer undergoing sentinel lymph node vs. complete inguinal lymph node dissection. Patients and Methods...
- Necessity of colposcopy and biopsy prior to large loop excision of the transformation zone (LLETZ)
[作者:Hefler, L; Polterauer, S; Nowotny, G; Tempfer, C; Kohlberger, P; Sliutz, G; Speiser, P; Joura, E; Reinthaller, A,期刊:Anticancer Research, 页码:519-521 , 文章类型: Article,,卷期:2008年28-1B]
- Background: The clinical value of colposcopy and biopsy prior to large loop excision of the cervical transformation zone (LLETZ) with respect to negative histology and positive specimen margin rates, was evaluated. Patie...
- Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: A single institution experience
[作者:Kotteas, E; Alamara, C; Kiagia, M; Pantazopoulos, K; Boufas, A; Provata, A; Charpidou, A; Syrigos, KN,期刊:Anticancer Research, 页码:529-533 , 文章类型: Article,,卷期:2008年28-1B]
- Zoledronic acid (Zometa (TM), Novartis, Basel, Switzerland) is a new generation of bisphosphonates (BPs) with demonstrated clinical benefit in breast and prostate cancer patients with bone metastases. The safety and effi...
- Clinicopathological features of lipomas with gene fusions involving HMGA2
[作者:Hatano, H; Morita, T; Ogose, A; Hotta, T; Kobayashi, H; Segawa, H; Uchiyama, T; Takenouch, T; Sato, T,期刊:Anticancer Research, 页码:535-538 , 文章类型: Article,,卷期:2008年28-1B]
- Background: Despite accumulating knowledge of chimeric genes derived from fusion of the HMGA2 gene with multiple partners in lipomas, the different clinicopathological features of lipomas depending on different gene aber...
- Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: A retrospective analysis
[作者:Papadoniou, N; Kosmas, C; Gennatas, K; Polyzos, A; MouratidoU', D; Skopelitis, E; Tzivras, M; Sougioultzis, S; Papastratis, G; Karatzas, G; Papalambros, E; Tsavaris, N,期刊:Anticancer Research, 页码:543-549 , 文章类型: Article,,卷期:2008年28-1B]
- Background: Most patients with pancreatic adenocarcinoma are diagnosed with locally advanced (unresectable) or metastatic disease. The aim of this study was to investigate possible prognostic factors of survival in such ...
- Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression
[作者:Marioni, G; Giacomell, L; D'Alessandr, E; Staffieri, C; Guzzard, V; Staffieri, A; Blandamura, S,期刊:Anticancer Research, 页码:551-557 , 文章类型: Article,,卷期:2008年28-1B]
- Background: Tumour angiogenesis is the result of an inbalance between anti- and pro-angiogenic factors. CD105 (endoglin) is a component of the receptor complex of transforming growth factor (TGF-beta 1). Vascular endothe...
- Successful treatment with S-1 plus CPT-11 for lymph node metastasis from colon cancer: Report of a case
[作者:Yoshimatsu, K; Fujimoto, HYT; Otani, T; Matsumoto, A; Osawa, G; Itagaki, H; Umehara, A; Shiozawa, S; Katsube, T; Naritaka, Y; Ogawa, K,期刊:Anticancer Research, 页码:559-562 , 文章类型: Article,,卷期:2008年28-1B]
- S-1 is a novel oral anticancer drug, composed of tegafur (FT), gimestat (CDHP) and otastat potassium (Oxo), based on the biochemical modulation of 5-fluorouracil (5-FU). S-1 plus irinotecan (CPT-11) for advanced colorect...
|